MEI Pharma, Inc. (NASDAQ:MEIP)

CAPS Rating: 1 out of 5

A development stage company, engaged in the clinical development of the anti-cancer drug phenoxodiol.

Recs

0
Player Avatar scrubs62074 (88.85) Submitted: 2/13/2013 11:17:30 AM : Outperform Start Price: $5.03 MEIP Score: +46.02

High Volume Breakout on 02/13/13

Featured Broker Partners


Advertisement